Investment Q&A

Q: Hi 5i,
I have 3 different questions- please deduct accordingly.
1.) Since March 24 KEY (+12.46%) has outperformed each of ENB (+6.21%), TRP (+8.75) and PPL (+8.06%) by fairly substantial margins. I know that's a short time frame, but can you offer an explanation for KEY's better performance, and would you expect it to continue to lead the others over the next year?
2.) GSY is at or close to its lowest level since January 2021 - do you think the relevant company, sector and economy related bad news is now priced in and expect it to recover to the $150 range over 12 - 18 months, or do you think that's a pipe dream, and why or why not?
3.) In your opinion is ET likely to recover to at least the $14.00 level (where I bought it some time ago) this calendar year - and why or why not.
Thanks!
Peter

Q: I own this company as it has sunk steadily. Hold or sell? What do you think? take my beating and invest in something else? thanks

Q: For this 10-stock all-equity TFSA portfolio (for 30-yr-old Albertan), which has 40% cash available to invest:
(a) which one or more of the 10 stocks would you suggest adding to?
(b) which new stock ideas do you feel would complement this portfolio (please suggest 5 or 6)?
NOTE: The philosophy is long-term buy & hold with minimal trading.
CURRENT HOLDINGS (weight in portfolio)
TD bank (13%)
Suncor (13%)
TC Energy (12%)
CPKC Rail (11%)
Amazon (10%)
Nutrien (10%)
Visa (9%)
Aritzia (9%)
Air Canada (8%)
Copper Mountain (6%)

Ted

Q: Peter and His Wonder Team
I thought they just reported a good quarter and yet the stock is down. What am I missing? Thanks for your assessment of this stock.

Q: The Dec financials show restricted cash held by NVEI, Please advise the reason for the restriction.
Thanks
Mike

Q: In a question today you included PPL as a potential takeover. Why did you include PPL and who do you think would be the interested party?

Q: I am following the above through Investor Suite which was a pick a while back. Morpheus appears to be the purchaser.
Is 5i is going to follow, or should this be just dropped.
Just wondering and thanks for your reply
Rick

Q: Hi There,

With the stock price down to 7.85 approx due to the bought deal, all things considered would you advise a holder to add to holdings at this time?

Thanks! Rob

Q: Hi 5i
A month ago you suggested waiting a few weeks for the turmoil in regional banks to settle down. Are we there yet? I am tempted to buy IAT (35.28) or KRE (42.65), both about 35% off their highs. thoughts?
Greg

Q: Can I get your take on Firan Technologies’ recent quarter and do you think it’s a good small cap buy? Thanks

Q: Why is there this marked difference between WTI & WCS? Is it because western Canadian oil is land locked? Is it a squeeze caused by US refineries who know there is no alternative to them as a buyer at this time? Will this difference improve when the Canadian pipeline to British Columbia is finished? The difference now is about $16.00 but at times it can be $30.00.
Thanks Dave

Q: I currently own ABBV. I am aware of the off-patent cliff for Humira. Earnings are expected to drop when they are announced at the end of this month. I'm not so sure their other two drugs - Rinvoq and Skyrizi - will be capable of picking up the slack. I had read a recent article, and it gave me the impression that Humira and its new biosimilar competitors have some active ingredient(s) that allows them to be used for patients using Rinvoq and Skyrizi (?) In other words, I'm wondering if the upside of Rinvoq and Skyrizi is limited. I think you like ABBV, but is there any concern longterm? The market doesn't appear to be pricing in the risks.

I've pared back some of my ABBV shares, and am considering selling the rest. Alternatively, how robust is Amgen's pipeline in comparison ? LLY looks historically expensive, and I already own JNJ.

Q: Hi there,

Spruce Point put out an update on their short today. What is your opinion on this? Is there any merit? Or alternatively, does this present a buying opportunity?

Thanks!

Q: Hi 5i team! Brookfield defaulted again yesterday on a dozen office buildings in Washington DC. In February it was on 2 buildings in Los Angeles. Should we be concerned or is this not material? Thanks

Q: I would like to have a look ahead on both companies.Would TOU look at selling TPZ if the price was right and how would that affect TOU revenues and Dividend or would they sell both TOU. & Tpz if price was right.Mr Rose has already sold. Companies before.I understandTOU has some long term contracts. What does 5i crystal ball foresee in the future,s .Maybe some rich US company flush with cash look at them or would it be expensive for them. I enjoy the dividends,take your time I have many points to redem

Q: Could you please name some Canadian companies you think have a good chance of being taken over? Thank you

Q: Hello Peter et al,

From your answers your faith and belief in GOOG seems unshakeable! Would say it is worth nibbling at this price? Or is it worth buying cash covered puts and be ready if assigned? In other words, wade in gradually (DCA as per your recent editorial in CMS!) or use options strategy? If you do hazard a guess, what would be the floor for GOOG? 90$? Your crystal ball is as good as anyone's on CNBC!!

Mano.

P.S. BTW miss you at BNN! You folks may want to consider regular webinars for the subscribers with a Q&A function.

Q: Looking to make purchase a couple of stocks for TFSA. Looking at ATD, MG, DOO and CNR. How would you rank the above. Are there other similar stocks that you would prefer instead. Looking for a stable, high quality company with good earnings and cashflow.

Q: Any thoughts on David Rosenberg article in the Globe today? Are we that close to a shift to a a profitable bond market? If so your top two picks. Thank you

Q: Please provide an update on NLH many thanks.